163 related articles for article (PubMed ID: 36516105)
1. Re-Examining Cannabidiol: Conversion to Tetrahydrocannabinol Using Only Heat.
Daniels R; Yassin OA; Toribio JM; Gascón JA; Sotzing G
Cannabis Cannabinoid Res; 2024 Apr; 9(2):486-494. PubMed ID: 36516105
[No Abstract] [Full Text] [Related]
2. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
3. Copper Stimulation of Tetrahydrocannabinol and Cannabidiol Production in Hemp (
Cahill MS; Arsenault T; Bui TH; Zuverza-Mena N; Bharadwaj A; Prapayotin-Riveros K; White JC; Dimkpa CO
J Agric Food Chem; 2024 Apr; 72(13):6921-6930. PubMed ID: 38516700
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products.
Zamarripa CA; Tilton HE; Lin S; Cone EJ; Winecker RE; Flegel RR; Kuntz D; Beals M; Jacques M; Clark M; Welsh ER; Wagner L; Bonn-Miller MO; Vandrey R; Spindle TR
J Anal Toxicol; 2024 Mar; 48(2):81-98. PubMed ID: 38217086
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill.
Zawatsky CN; Mills-Huffnagle S; Augusto CM; Vrana KE; Nyland JE
Med Cannabis Cannabinoids; 2024; 7(1):10-18. PubMed ID: 38352661
[TBL] [Abstract][Full Text] [Related]
6. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Cannabidiol, Δ
ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
[TBL] [Abstract][Full Text] [Related]
8. Complexity of Translating Analytics to Recent Cannabis Use and Impairment.
DeGregorio MW; Kao CJ; Wurz GT
J AOAC Int; 2024 May; 107(3):493-505. PubMed ID: 38410076
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract.
Wakshlag JJ; Schwark WS; Deabold KA; Talsma BN; Cital S; Lyubimov A; Iqbal A; Zakharov A
Front Vet Sci; 2020; 7():505. PubMed ID: 33102539
[TBL] [Abstract][Full Text] [Related]
11. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
12. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
[TBL] [Abstract][Full Text] [Related]
13. Opportunities, Challenges, and Scientific Progress in Hemp Crops.
Kaminski KP; Hoeng J; Goffman F; Schlage WK; Latino D
Molecules; 2024 May; 29(10):. PubMed ID: 38792258
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
15. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
16. Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Lachenmeier DW; Habel S; Fischer B; Herbi F; Zerbe Y; Bock V; Rajcic de Rezende T; Walch SG; Sproll C
F1000Res; 2019; 8():1394. PubMed ID: 32117565
[TBL] [Abstract][Full Text] [Related]
17. Origin of Δ
Citti C; Russo F; Linciano P; Strallhofer SS; Tolomeo F; Forni F; Vandelli MA; Gigli G; Cannazza G
Cannabis Cannabinoid Res; 2021; 6(1):28-39. PubMed ID: 33614950
[No Abstract] [Full Text] [Related]
18. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
